Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1356

1.

Retrospective cost-effectiveness analysis of screening mammography.

Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG.

J Natl Cancer Inst. 2006 Jun 7;98(11):774-82.

2.

Cost effectiveness of mammography screening for Chinese women.

Wong IO, Kuntz KM, Cowling BJ, Lam CL, Leung GM.

Cancer. 2007 Aug 15;110(4):885-95. Erratum in: Cancer. 2010 Jan 15;116(2):540.

3.

Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.

Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ.

J Natl Cancer Inst. 2008 Sep 17;100(18):1290-300. doi: 10.1093/jnci/djn292. Epub 2008 Sep 9.

4.

Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.

de Gelder R, Bulliard JL, de Wolf C, Fracheboud J, Draisma G, Schopper D, de Koning HJ.

Eur J Cancer. 2009 Jan;45(1):127-38. doi: 10.1016/j.ejca.2008.09.015. Epub 2008 Nov 27.

PMID:
19038540
5.

Mammography screening for older women with and without cognitive impairment.

Messecar DC.

J Gerontol Nurs. 2000 Apr;26(4):14-24; quiz 52-3.

PMID:
11272962
6.
7.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

8.

Cost-effectiveness of breast cancer screening in women on dialysis.

Wong G, Howard K, Chapman JR, Craig JC.

Am J Kidney Dis. 2008 Nov;52(5):916-29. doi: 10.1053/j.ajkd.2008.06.015. Epub 2008 Sep 11.

PMID:
18789566
9.

Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.

Salzmann P, Kerlikowske K, Phillips K.

Ann Intern Med. 1997 Dec 1;127(11):955-65. Erratum in: Ann Intern Med 1998 May 15;128(10):878.

PMID:
9412300
10.

Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.

Schousboe JT, Kerlikowske K, Loh A, Cummings SR.

Ann Intern Med. 2011 Jul 5;155(1):10-20. doi: 10.7326/0003-4819-155-1-201107050-00003.

11.

A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration.

Karnon J, Czoski-Murray C, Smith K, Brand C, Chakravarthy U, Davis S, Bansback N, Beverley C, Bird A, Harding S, Chisholm I, Yang YC.

Health Technol Assess. 2008 Jun;12(27):iii-iv, ix-124.

12.

A cost utility analysis of mammography screening in Australia.

Hall J, Gerard K, Salkeld G, Richardson J.

Soc Sci Med. 1992 May;34(9):993-1004.

PMID:
1631612
13.

Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.

Hutton DW, Tan D, So SK, Brandeau ML.

Ann Intern Med. 2007 Oct 2;147(7):460-9.

PMID:
17909207
14.

What is the most cost-effective population-based cancer screening program for Chinese women?

Woo PP, Kim JJ, Leung GM.

J Clin Oncol. 2007 Feb 20;25(6):617-24.

15.

The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force.

Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu AL, Atkins D, Klein J, Helfand M; Cost Work Group of the U.S. Preventive Services Task Force.

Ann Intern Med. 2003 Nov 18;139(10):835-42. Review.

PMID:
14623621
16.

The cost-effectiveness of screening for oral cancer in primary care.

Speight PM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M, Augustovski F.

Health Technol Assess. 2006 Apr;10(14):1-144, iii-iv. Review.

17.

Breast cancer screening; cost-effective in practice?

De Koning HJ.

Eur J Radiol. 2000 Jan;33(1):32-7.

PMID:
10674787
18.

Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis.

Hu D, Hook EW 3rd, Goldie SJ.

Ann Intern Med. 2004 Oct 5;141(7):501-13. Erratum in: Ann Intern Med. 2004 Nov 2;141(9):744.

PMID:
15466767
19.

Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.

Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, Buist DS, Cevik M, Chisholm G, de Koning HJ, Huang H, Hubbard RA, Miglioretti DL, Munsell MF, Trentham-Dietz A, van Ravesteyn NT, Tosteson AN, Mandelblatt JS.

J Natl Cancer Inst. 2014 May 28;106(6):dju092. doi: 10.1093/jnci/dju092. Print 2014 Jun.

20.

Measuring cost-effectiveness of surgical procedures.

Subak LL, Caughey AB.

Clin Obstet Gynecol. 2000 Sep;43(3):551-60. Review.

PMID:
10949758
Items per page

Supplemental Content

Write to the Help Desk